US2005202055A1PendingUtilityA1

Anti-wrinkle agent

Assignee: KOICHI SHUDO TOKYO JAPANPriority: Mar 11, 2004Filed: Sep 2, 2004Published: Sep 15, 2005

Est. expiryMar 11, 2024(expired)· nominal 20-yr term from priority

Inventors:Koichi Shudo Seishiro Fujii

A61P 43/00A61P 17/00A61K 31/196A61K 31/695A61K 31/195A61P 17/16A61K 31/167

PatentIndex Score

Cited by

References

Claims

Abstract

A medicament having an anti-wrinkle action, which comprises as an active ingredient a retinoid having a fundamental structure of a phenyl substituted carbamoyl benzoic acid or a phenyl substituted carboxamide benzoic acid (for example, 4-(2,4-bistrimethylsilylphenylcarboxamide)benzoic acid, 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid, or the like).

Claims

exact text as granted — not AI-modified

1 . A medicament having an anti-wrinkle action, which comprises as an active ingredient a retinoid having a fundamental structure of a phenyl substituted carbamoyl benzoic acid or a phenyl substituted carboxamide benzoic acid.  
     
     
         2 . The medicament according to  claim 1 , wherein the retinoid does not substantially bind to a retinoic acid receptor (RAR) subtype y.  
     
     
         3 . The medicament according to  claim 1 , wherein the retinoid is 4-(2,4-bistrimethylsilyphenylcarboxamide)benzoic acid or 4-[(5, 6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid.  
     
     
         4 . The medicament according to  claim 2  wherein the retinoid is 4-(2,4-bistrimethylsilyphenylcarboxamide) benzoic acid or 4-[(5, 6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid.

Join the waitlist — get patent alerts

Track US2005202055A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.